Successful treatment of severe abulia with co-beneldopa

NeuroRehabilitation

Volumn 29, Issue 4, 2011, Pages 347-351

  Bakheit, A M O ^a   Fletcher, K ^a   Brennan, A ^a  

^a Moseley Hall Hospital   (United Kingdom)

Author keywords

Abulia treatment; akinetic mutism; levodopa therapy

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DOMPERIDONE; SODIUM CHLORIDE;

ABULIA; AGED; AKINETIC MUTISM; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; FEMALE; FRONTAL LOBE; HUMAN; HYDROCEPHALUS; INAPPROPRIATE VASOPRESSIN SECRETION; LIMBIC SYSTEM; MENINGIOMA; MORNING DOSAGE; NAUSEA; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOMOTOR RETARDATION; TREATMENT RESPONSE;

BENSERAZIDE; CRANIAL FOSSA, POSTERIOR; DOPAMINE AGENTS; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROCEPHALUS; LEVODOPA; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PSYCHOMOTOR DISORDERS; SPEECH DISORDERS;

EID: 84856823730     PISSN: 10538135     EISSN: 18786448     Source Type: Journal    
DOI: 10.3233/NRE-2011-0711     Document Type: Article

References (25)

1. S. Al-Adawi, G.S. Dawe and A.A. Al-Hussaini, Abulia: neu-robehavioural dysfunction of dopaminergic system, Medical Hypotheses 54 (2000), 523-530. (Pubitemid 30311540)
2. K. Barrett, Treating organic abulia with bromocriptine and lisuride: four case studies, Journal of Neurology Neurosurgery and Psychiatry 54 (1991), 718-721.
3. K.P. Bhatia and C.D. Marsden, The behavioural and motor consequences of focal lesions of the basal ganglia in man, Brain 117 (1994), 859-876. (Pubitemid 24281846)
4. H. Cairns, R.C. Oldfield, J.B. Pennybacker and D. Whit-teridge, Akinetic mutism with an epidermoid cyst of the 3rd ventricle, Brain 64 (1941), 273-290.
5. O. Combarros, J. Infante and J. Berciano, Akinetic mutism from frontal lobe damage responding to levodopa, Journal of Neurology 247 (2000), 568-569. (Pubitemid 30598890)
6. J.L. Cummings, Frontal-subcortical circuits and human behavior, Archives of Neurology 50 (1993), 873-80. (Pubitemid 23229317)
7. D.A. Drubach, G. Zeilig, J. Perez, L. Perlata and M. Makley, Treatment of abulia with carbidopa, Neurorehabiluitation and Neural Repair 9 (1995), 151-155.
8. C.M. Fisher, Honored guest presentation: abulia minor vs. agitated behavior, Clinical Neurosurgery 31 (1983), 9-31.
9. C.M. Fisher, Abulia, in: Stroke syndromes, J. Bogousslavsky and L. Caplan, eds, Cambridge University Press: Cambridge, 1995.
10. J.M. Fuster, Functional neuroanatomy of executive process, in: The Handbook of Clinical Neuropsychology: Second Edition, J.M. Gurd, U. Kischka and J.C. Marshall, eds, Oxford University Press: Oxford, New York, 2010.
11. R.A. Hauser, W.C. Koller, J.P. Hubble, T. Malapira, K. Busen-bark and C.D. Olanow, Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocrip-tine in early Parkinson's disease, Movement Disorders 15 (2000), 485-489. (Pubitemid 30333220)
12. A.F. Jorm and P.A. Jacomb, The informant questionnaire on cognitive decline in the elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms, Psychological Medicine 19 (1989), 1015-1022. (Pubitemid 20012268)
13. J.L. Juncos, Levodopa: pharmacology, pharmacokinetics and pharmacodynamics, Neurologic Clinics 10 (1992), 487-509.
14. R.S. Marit and P.A. Wilkosz, Disorders of diminished motivation, Journal of Head Trauma Rehabilitation 20 (2005), 377-388. (Pubitemid 40923449)
15. N. Nargatnam, S. Fanella, S. Gopinath and A. Goodwin, Prolonged abulia following putaminal haemorrhage, Journal of Stroke and Cerebrovascular Diseases 10 (2001), 92-93. (Pubitemid 32489099)
16. L. Pantoni, A.M. Basile, M. Romanelli, C. Piccini, C. Sarti, P. Nencini and D. Inzitari, Abulia and cognitive impairment in two patients with capsular genu infarct, Acta Neurologica Scandinavica 104 (2001), 185-190. (Pubitemid 32831784)
17. J.H. Powell, S. Al-Adawi, J. Morgan and R.J. Greenwood, Motivational deficits after brain injury: effects of bromocrip-tine in 11 patients, Journal of Neurology, Neurosurgery and Psychiatry 60 (1996), 416-442.
18. T. Psarros, A. Zouros and C. Coimbra, Bromocriptine-responsive akinetic mutism after endoscopy for ventricular neurocysticercosis: case report and review of the literature, Journal of Neurosurgery 99 (2003), 397-401. (Pubitemid 36900135)
19. C. Randolph, M.C. Tierney, E. Mohr and T.N. Chase, The Repeatable Battery for the Assessment of Neuropsychologi-cal Status (RBANS): preliminary clinical validity, Journal of Clinical & Experimental Neuropsychology 20 (1998), 310-319. (Pubitemid 28539551)
20. H. Rickards, Psychopharamcological treatment of executive disorders following brain injury, in: The Rehabilitation of Executive Disorders, M. Oddy and A. Worthington, eds, Oxford University Press: Oxford, New York, 2009.
21. E.D. Ross and R.M. Stewart, Akinetic mutism from hypotha-lamic damage: successful treatment with dopamine agonists, Neurology 31 (1981), 1435-1439. (Pubitemid 12228278)
22. D.T. Stuss, Rehabilitation of frontal lobe function: a working framework, in: The Rehabilitation of Executive Disorders, M. Oddy and A. Worthington, eds, Oxford University Press: Oxford, New York, 2009.
23. C. Tengvar, B. Johansson and J. Sorensen, Frontal lobe and cingulate cortical metabolic dysfunction in acquired akinetic mutism: a PET study of the interval form of carbon monoxide poisoning, Brain Injury 18 (2004), 615-625. (Pubitemid 38584637)
24. L. Vijayaraghavan, E.S. Krishnamoorthy, R.G. Brown and M.R. Trimble, Abulia: a delphi survey of British neurologists and psychiatrists, Movement Disorders 17 (2002), 1052-1057. (Pubitemid 36041014)
25. D. Wechsler, Wechsler Test of Adult Reading (WTAR), San Antonio, TX: The Psychology Corporation, 2001.